Grigoriy Rodonaia
Family Medicine · Beaumont, TXNPI 1023210317
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $680 and has fallen 94.4% since, to $38 in 2021.
Across 92 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$206
- Kowa Pharmaceuticals America, Inc.$147
- Pfizer$136
- Arbor Pharmaceuticals, Inc.$135
- Supernus Pharmaceuticals, Inc.$129
- Lilly USA, LLC$116
- plus $451 from 14 others
What the payments were for
- Food & beverage$1,320100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $206 |
| Kowa Pharmaceuticals America, Inc. | 11 | $147 |
| Pfizer | 10 | $136 |
| Arbor Pharmaceuticals, Inc. | 11 | $135 |
| Supernus Pharmaceuticals, Inc. | 11 | $129 |
| Lilly USA, LLC | 8 | $116 |
| AbbVie | 7 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Sunovion Pharmaceuticals Inc. | 6 | $53 |
| Aytu Biopharma, Inc. | 2 | $42 |
| Mylan Specialty L.p. | 2 | $35 |
| Ultragenyx Pharmaceutical Inc. | 2 | $34 |
| Novo Nordisk | 1 | $24 |
| Optos, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Amgen | 1 | $12 |
| Merck | 1 | $12 |
| Daiichi Sankyo Inc. | 1 | $11 |
How this compares
$1,320 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Beaumont
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.